We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+4.61%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$6.45B
AUM Growth
+$506M
Cap. Flow
+$374M
Cap. Flow %
5.8%
Top 10 Hldgs %
9.06%
Holding
1,544
New
115
Increased
307
Reduced
320
Closed
116

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$36.5M
2
SNDK
SANDISK CORP
SNDK
+$35.2M
3
LUV icon
Southwest Airlines
LUV
+$24.1M
4
WM icon
Waste Management
WM
+$22.3M
5
PGR icon
Progressive
PGR
+$22M

Sector Composition

Rank Sector Weight
1 Financials 21.1%
2 Industrials 14.47%
3 Technology 11.04%
4 Consumer Staples 9.5%
5 Consumer Discretionary 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IESC icon
1301
IES Holdings
IESC
$14.4B
$206K ﹤0.01%
16,617
NVET
1302
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$206K ﹤0.01%
44,400
FMNB icon
1303
Farmers National Banc Corp
FMNB
$937M
$202K ﹤0.01%
23,000
+300
+1% +$2.74K
AAMI
1304
Acadian Asset Management
AAMI
$2.92B
$202K ﹤0.01%
+15,100
New +$211K
AINC
1305
DELISTED
Ashford Inc.
AINC
$200K ﹤0.01%
4,000
-6,600
-62% -$324K
ZN
1306
DELISTED
Zion Oil & Gas, Inc.
ZN
$198K ﹤0.01%
142,385
+10,100
+8% +$16.6K
MPU icon
1307
Mega Matrix
MPU
$16M
$194K ﹤0.01%
105,000
PLX icon
1308
Protalix BioTherapeutics
PLX
$180M
$194K ﹤0.01%
30,259
-4,696
-13% -$37.5K
RKDA icon
1309
Arcadia Biosciences
RKDA
$1.37M
$194K ﹤0.01%
+94
New +$157K
SALE
1310
DELISTED
RetailMeNot, Inc. Series 1
SALE
$193K ﹤0.01%
25,000
-25,700
-51% -$196K
HNR
1311
DELISTED
Harvest Natural Resources
HNR
$192K ﹤0.01%
57,350
HPJ
1312
DELISTED
Highpower International Inc
HPJ
$192K ﹤0.01%
101,845
-183,200
-64% -$356K
FNWB icon
1313
First Northwest Bancorp
FNWB
$111M
$191K ﹤0.01%
15,000
UNTY icon
1314
Unity Bancorp
UNTY
$590M
$191K ﹤0.01%
16,500
SKY icon
1315
Champion Homes
SKY
$4.3B
$189K ﹤0.01%
+20,100
New +$186K
TNXP icon
1316
Tonix Pharmaceuticals
TNXP
$155M
0
ENG
1317
DELISTED
ENGlobal Corp
ENG
$188K ﹤0.01%
19,538
-1,650
-8% -$15.9K
SEAC
1318
DELISTED
Seachange International Inc
SEAC
$187K ﹤0.01%
2,925
+1,950
+200% +$144K
ARLZ
1319
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$184K ﹤0.01%
55,686
-37,514
-40% -$142K
CAAS icon
1320
China Automotive Systems
CAAS
$130M
$183K ﹤0.01%
56,700
AIQ
1321
DELISTED
Alliance Healthcare Services
AIQ
$182K ﹤0.01%
29,200
-40,900
-58% -$281K
ATLC icon
1322
Atlanticus Holdings
ATLC
$1.59B
$181K ﹤0.01%
62,112
CNXR
1323
DELISTED
Connecture, Inc.
CNXR
$181K ﹤0.01%
80,200
IMN
1324
DELISTED
Imation
IMN
$181K ﹤0.01%
145,100
-50,000
-26% -$78.9K
MOCO
1325
DELISTED
Mocon Inc
MOCO
$181K ﹤0.01%
12,800

Similar funds

Bridgeway Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Bridgeway Capital Management held 1,544 positions worth $6.45B, up 8.5% from $5.94B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Bridgeway Capital Management deployed $374M of net new capital in Q2 2016, opening 115 new positions and adding to 307 existing holdings. Its largest new stake was Quest Diagnostics: 595,800 shares worth $48.5M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Southwest Airlines, an estimated $24.1M trimmed.

  • Bridgeway Capital Management's largest Q2 2016 buy was Quest Diagnostics: 595,800 shares worth $48.5M.
  • Bridgeway Capital Management added most to UnitedHealth in Q2 2016, an estimated $39.6M increase.
  • Bridgeway Capital Management's biggest Q2 2016 reduction was Southwest Airlines, cutting an estimated $24.1M.
  • Bridgeway Capital Management fully exited Cigna in Q2 2016, selling an estimated $36.5M.
  • Bridgeway Capital Management's ten largest holdings make up 9.1% of its $6.45B portfolio in Q2 2016.
  • Bridgeway Capital Management opened 115 new positions and closed 116 in Q2 2016.
  • Bridgeway Capital Management's portfolio value rose 8.5% quarter-over-quarter to $6.45B.

Based on Bridgeway Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.